Tci Wealth Advisors, Inc. Natera, Inc. Transaction History

Tci Wealth Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$36.57 - $58.29 $548 - $874	-15 Reduced 10.79%	124 $6,000
Q4 2022 Feb 06, 2023	BUY	$34.17 - $47.91 $580 - $814	17 Added 13.93%	139 $5,000
Q2 2022 Jul 19, 2022	BUY	$28.13 - $44.54 $1,322 - $2,093	47 Added 62.67%	122 $4,000
Q1 2022 Apr 29, 2022	SELL	$30.32 - $91.33 $2,274 - $6,849	-75 Reduced 50.0%	75 $3,000
Q4 2021 Jan 24, 2022	SELL	$86.26 - $119.0 $13,629 - $18,802	-158 Reduced 51.3%	150 $14,000
Q3 2021 Oct 29, 2021	BUY	$100.17 - $126.36 $3,105 - $3,917	31 Added 11.19%	308 $34,000
Q2 2021 Aug 02, 2021	BUY	$86.05 - $119.72 $4,302 - $5,986	50 Added 22.03%	277 $31,000
Q1 2021 Apr 29, 2021	BUY	$91.47 - $124.36 $13,903 - $18,902	152 Added 202.67%	227 $23,000
Q2 2019 Jul 23, 2019	SELL	$17.75 - $27.58 $621 - $965	-35 Reduced 31.82%	75 $2,000
Q1 2019 Apr 11, 2019	BUY	$11.34 - $20.62 $396 - $721	35 Added 46.67%	110 $2,000
Q4 2018 Jan 17, 2019	BUY	$12.32 - $24.38 $924 - $1,828	75 New	75 $1,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.